Azul Optics Analysis
Azul Optics is a health care startup, founded in 2015 and based in the United Kingdom. The company's slogan, "MP-eye score increases patient use of sunglasses/photochromics, blue filtering lenses and macular pigment supplements," reflects its focus on developing innovative screening tools to prevent eye disease.
Azul Optics' flagship product, MP-eye, helps eyecare professionals identify patients at increased risk of eye disease. This tool not only provides a measurement but also initiates a conversation with patients about products that can improve and protect their sight, such as sunglasses, photochromics, blue light filtering lenses, and macular pigment supplements. Additionally, the MP-eye score serves as quantitative evidence that scientifically justifies and compels patients to invest in the protection of their eyes. Through this approach, eyecare professionals can differentiate their practice and increase revenues by offering preventative and protective products.
The company received its Series B investment on 07 April 2017 from Parkwalk Advisors, showcasing investor confidence in Azul Optics' mission and potential impact in the eyecare industry.
This investment is a testament to the company's innovative approach and its potential to drive positive change in the eyecare sector.No recent news or press coverage available for Azul Optics.